Clinical Trial Update: Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/Phase 2 trial evaluated a novel taxane in combination with capecitabine for metastatic breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Investigational taxane

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer, Cancer | Phase 1, Phase 2 | Status: COMPLETED